Gemma Biotherapeutics ("GEMMABio"), a clinical-stage, global, genetic medicines company, today announced that it has been awarded funding by the Advanced Research Projects Agency for Health (ARPA-H).

As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...

A trio of common amino acids may hold the key to unlocking far more powerful gene therapies. Researchers found that adding them to lipid nanoparticles can boost mRNA delivery up to 20-fold and push ...

Scientists may have been wrong about mRNA vaccines — and they’re thrilled. While mRNA vaccines are already proven safe and effective, scientists are just now uncovering new details about how they work ...

Moderna's MRNA.O mRNA-based seasonal flu vaccine worked better than conventional flu shots in a late-stage international trial of more than 40,000 adults aged 50 and older, researchers reported on ...

The efficacy of flu shots is not always the same and it’s not always optimal. Some years, they can reduce the risk of illness by as little as 20% to 30%. Subscribe to read this story ad-free Get ...

Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines with the potential to significantly boost the immune system’s ability to ...

Since the COVID-19 pandemic, mRNA vaccines have gained attention as a next-generation pharmaceutical technology. mRNA therapeutics work by delivering genetic instructions that enable cells to produce ...

Vivek Ahuja, VP-IT at rSTAR, spearheading business and IT transformation with a focus on manufacturing, energy/utilities and construction. Enterprise software development is hitting a breakpoint. The ...

Researchers tracked more than 400 toddlers to see whether mRNA COVID-19 vaccination during or just before pregnancy was linked to autism or developmental delays. After detailed assessments of speech, ...

Goose acts as the agent that plans, iterates, and applies changes. Ollama is the local runtime that hosts the model. Qwen3-coder is the coding-focused LLM that generates results. If you've been ...

In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...